FDA Says It Caved To Politics In Clearing ReGen Implant

Law360, Washington (March 14, 2013, 10:28 PM EDT) -- The U.S. Food and Drug Administration said Thursday it had acted within its authority when it rescinded marketing clearance for a ReGen Biologics Inc. knee implant — an action the company says drove it into bankruptcy — because the device had gotten initial approval only due to "severe political pressure."

FDA attorneys claimed during a summary judgment hearing Thursday that the agency was under “one of the most severe political pressures” it had ever seen when it first approved ReGen's collagen meniscus implant, Menaflex, as a...
To view the full article, register now.

Related

Sections

Case Information

Case Title

REGEN BIOLOGICS, INC. v. SEBELIUS et al


Case Number

1:11-cv-01006

Court

District Of Columbia

Nature of Suit

Other Statutory Actions

Judge

Rudolph Contreras

Date Filed

May 31, 2011

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.